Safety and Efficacy of MAK683 in Adult Patients With Advanced Malignancies
Clinical trial NCT02900651 · TERMINATED
Trial details
- NCT number
- NCT02900651
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-03
- Primary completion
- 2024-10-09
- Enrollment
- 139
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.